On-X Life Technologies, Inc. Release: Economic Model of the Life-time Cost Impact of Heart Valve Prosthetic Choice to be Presented at ISPOR Meeting
5/21/2013 8:05:14 AM
More...
|
Enrollment Completed for Low-Risk Aortic and Mitral Patient Groups For On-X Life Technologies, Inc.® Prosthetic Heart Valve Anticoagulation Clinical Study
5/7/2013 11:18:54 AM
More...
|
AATS Report: Prospective Randomized On-X Life Technologies, Inc. Heart Valve Clinical Trial (PROACT) Provides Evidence of Reduced Complications
5/7/2013 9:04:18 AM
More...
|
On-X Life Technologies, Inc. Release: Story Predicting Long-Term Costs of Heart Valve Replacement Study to be Presented at American College of Cardiology Meeting
3/8/2013 9:23:28 AM
More...
|
On-X Life Technologies, Inc. Receives FDA Approval for On-X Heart Valve With Anatomic Shaped Sewing Ring
2/26/2013 11:41:58 AM
More...
|
On-X Life Technologies, Inc. Submits for FDA/CE Approval of Reduced Anticoagulation Indication for On-X Aortic Heart Valve
10/22/2012 11:15:54 AM
More...
|
On-X Life Technologies, Inc. Releases Educational Video for Prospective Heart Valve Replacement Patients
7/25/2012 9:09:16 AM
More...
|
On-X Life Technologies, Inc. to Highlight Reduced Anticoagulation Study Results, Long-Term and Patient Survival Data with the On-X Valve at STS Meeting
1/24/2012 10:20:24 AM
More...
|
On-X Life Technologies, Inc. Highlights 15 Years of Implant Excellence at the EACTS Meeting in Lisbon, Portugal
10/3/2011 2:21:10 PM
More...
|
On-X Life Technologies, Inc. Highlights 15 Years of Implant Excellence at the EACTS Meeting in Lisbon, Portugal
10/3/2011 1:18:31 PM
More...
|
|